Pilot Phase II Study of Temsirolimus in Patients With Recurrent Mixed Mesodermal and Mullerian Tumors (Carcinosarcoma) of the Uterus

Trial Profile

Pilot Phase II Study of Temsirolimus in Patients With Recurrent Mixed Mesodermal and Mullerian Tumors (Carcinosarcoma) of the Uterus

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2016

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Uterine cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
    • 18 Aug 2012 Status changed from suspended to recruiting as reported by University of Southern California Norris Comprehensive Cancer Center.
    • 29 Apr 2012 Status changed from recruiting to suspended as reported by University of Southern California Norris Comprehensive Cancer Center.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top